Subcutaneous (SC) Daratumumab (DARA) in Combination With...

Subcutaneous (SC) Daratumumab (DARA) in Combination With Standard Multiple Myeloma (MM) Treatment Regimens: An Open-label, Multicenter Phase 2 Study (PLEIADES)

Chari, Ajai, Goldschmidt, Hartmut, San-Miguel, Jesus, McCarthy, Helen, Suzuki, Kenshi, Hungria, Vania, Balari, Anna Sureda, Perrot, Aurore, Hulin, Cyrille, Magen, Hila, Iida, Shinsuke, Maisnar, Vladim
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.09.023
Date:
October, 2019
File:
PDF, 84 KB
2019
Conversion to is in progress
Conversion to is failed